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ABSTRACT
This paper provides a strategy for the assessment of brain
function in longitudinal cohort studies of children. The
proposed strategy invokes both domain-specific and
omnibus intelligence test approaches. In order to minimise
testing burden and practice effects, the cohort is divided
into four groups with one-quarter tested at 6-monthly
intervals in the 0–2-year age range (at ages 6 months, 1.0,
1.5 and 2.0 years) and at annual intervals from ages 3–20
(one-quarter of the children at age 3, another at age 4, etc).
This strategy allows investigation of cognitive development
and of the relationship between environmental influences
and development at each age. It also allows introduction of
new domains of function when age-appropriate. As far as
possible, tests are used that will provide a rich source of
both longitudinal and cross-sectional data. The testing
strategy allows the introduction of novel tests and new
domains as well as piloting of tests when the test burden is
relatively light. In addition to the recommended tests for
each age and domain, alternative tests are described.
Assessment methodology and knowledge about child
cognitive development will change over the next 20 years,
and strategies are suggested for altering the proposed test
schedule as appropriate.
This paper summarises the process of reviewing
and selecting outcome measures that assess cogni-
tive abilities as indicators of the development of
brain structure and function from the age of
6 months to 20 years and offers a strategy for
their use in epidemiological studies. This strategy
applies measures that are applicable in prospective
designs and allow description of the natural
development of cognitive skills while monitoring
potential environmental influences (eg, diet, social,
media, chemicals) on developmental trajectories.
This assessment plan assumes a comprehensive
evaluation of dimensions of intellectual develop-
ment that encompasses both appropriate aspects of
cognition and detection of vulnerable domains of
function at specific stages of development. The
strategy proposed is significantly influenced by the
neurocognitive and neuropsychological literature.
It is especially appropriate for interpreting devel-
opmental cognitive outcome data with regard to
brain-behaviour relationships.
An initial assessment issue involves resolving the
tension between testing ‘‘general intelligence’’ and
assessing neuropsychological functioning. In the
former case, an intelligence quotient (IQ) is
computed based on administration of standardised
omnibus tests. In the latter, domain-specific scores
are computed based on administration of specific
tests. This issue has received considerable attention
in the developmental neurotoxicology literature.
IQ tests have been used extensively in the study of
certain types of toxicant exposures (especially lead
and polychlorinated biphenyls (PCBs)), and it has
been argued that IQ tests are preferable to other
kinds of tests for their ‘‘public health value’’. This
belief posits that individuals besides psychologists
understand the meaning of such tests, and the
results are therefore more likely to be taken
seriously and acted upon by the public health
community and society at large.
In contrast, domain-specific neuropsychological
tests have received more attention in recent years
in behavioural toxicology because of their sensitiv-
ity to prenatal exposure to toxicants such as
methylmercury
1 and nicotine.
2 In addition, it has
been argued that these tests provide more insight
into the underlying central nervous system (CNS)
damage that may be associated with exposures,
since there is a significant literature that links
impaired performance within individual domains
or patterns of impaired and intact performance
across domains to specific types of brain damage
(structural, neural system, neurotransmitter).
Epidemiological designs can allow consideration
of both IQ and domain-specific outcomes at critical
stages of vulnerability during child development.
Such an approach provides the advantages of both
types of assessment approaches as well as the
potential to re-evaluate the results of existing
studies when new data are acquired.
DOMAINS OF RESEARCH INTEREST
Categorising the dimensions of cognition into
component parts is challenging even to cognitive
psychologists and neuropsychologists, who often
divide or subdivide these dimensions in different
ways. It is even more difficult to categorise existing
cognitive and behavioural tests since few were
designed to be pure tests of a specific aspect of
cognitive processing or a single domain. For the
purposes of developing a recommended battery,
domains were identified using the labels commonly
applied in clinical neuropsychology.
34In addition,
careful consideration was given to key aspects of
processing that should be assessed within each
domain. The following list identifies the domains
selected by the authors and associated defining
characteristics. The definitions are not meant to be
exhaustive but to give the reader an overview of the
types of skills subsumed under each domain and
assessed by associated neuropsychological tasks.
General intelligence/mental abilities/omnibus
cognitive skills tests
These tests consist of subtests with various labels
purported to measure aspects of cognitive function.
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measures such as IQ, often accompanied by omnibus measures
of verbal abilities (eg, Verbal IQ, Verbal Comprehension Index),
visual-motor or visuospatial skills (eg, Performance IQ, Perceptual
Organization Index), attention/working memory (eg, Working
Memory Index, Attention Index) or speed of processing (eg,
Processing Speed Index).
Academic skills
This domain includes skills such as reading words or paragraphs,
spelling and completing arithmetic problems.
Attention
This domain encompasses several processes including the
capacity to focus on and attend to stimuli over a period of
time (sustained attention, often assessed by Continuous
Performance Tests) and the capacity to take in and report back
stimuli immediately after presentation (eg, Forward Digit Span
or Visual Pointing Span).
Executive function/working memory
This is a complex domain that historically includes the
capacities to learn and manipulate stimuli (eg, Digit Span
Backward, Visual Pointing Span Backward), to invoke strategies
for manipulating novel stimuli (any task with a structure that
enhances task completion if recognised) or to solve novel
problems (problem solving tests). This domain includes skills
such as the ability to acquire the ‘‘set’’ of new tasks and to
maintain the set of the task while completing it as well as the
ability to flexibly switch from one set of task requirements to
another. Inhibition of dominant or distracting stimuli in order
to attend to critical stimuli is also included in this domain.
Language/verbal skills
This domain includes basic linguistic abilities such as the
capacity to produce phonemes, lexical development and
production of words, speech comprehension and linguistic
aspects of writing and reading. Language skills are often divided
into expressive and receptive components. Applied verbal skills,
such as vocabulary definitions, are sometimes included in this
domain.
Visuospatial abilities
These non-verbal abilities generally invoke the processing and
manipulation of visual designs, the spatial or physical aspects of
environmental objects or constructional skills. These abilities
are assessed by tasks such as drawing designs, recognising
objects presented in degraded form or embedded in a more
complex visual array, or assembling puzzles or block designs.
Constructional tasks involve motor output, but there are
visuospatial tasks that require simply the mental manipulation
of spatial information (eg, identifying the correct outline of an
object presented in cut-up form, matching faces, matching
angles).
Learning and memory
This domain encompasses several aspects of memory function.
Declarative memory is generally divided into anterograde and
retrograde memory function. Anterograde memory refers to the
learning of new information, retention of information over
shorter and longer delays, and the capacity for retrieval of
information from memory stores. It can be assessed using both
recall and recognition paradigms (recall paradigms get at the
individual’s capacity to retrieve information at will while
recognition paradigms are often better at assessing capacity
for learning and retention when retrieval problems exist).
Anterograde memory functions are sometimes divided into
verbal and visuospatial components, generally associated with
dominant and non-dominant memory function, although
visuospatial memory skills are also frequently affected in
individuals with basal ganglia and white matter dysfunction.
Anterograde memory is measured in many ways including the
presentation of stories, lists of words, designs or objects for
immediate learning, with delayed recall and recognition (multi-
ple choice) conditions. Retrograde memory refers to the capacity
to remember events or information from earlier stages of the
individual’s life. It can be tested using famous faces, questions
about historical events or facts, or questions about the
individual’s personal history. Procedural learning and memory
refers to the individual’s capacity to learn and remember a
problem-solving sequence (eg, reading words in a mirror) or a
motor skill (eg, driving a car).
Motor skills
These abilities refer to the individual’s capacity to carry out
manual motor activities. Using neuropsychological tests, they
are generally assessed using the hands (manual motor dexter-
ity), with evaluation of speed and accuracy. Tasks may be
relatively simple (tapping a computer key or finger tapping
apparatus), complex and requiring coordination as well as speed
(pegboard tasks) or integrative (writing or typing symbols to
match digits on a coding task).
Other domains can be included if relevant or if standardised
tests become available. These include expressive and receptive
prosody, motivation/malingering and tactile/kinesthetic func-
tion. Tasks assessing the above domains and conditions under
which they might be applied are discussed in this paper.
METHODS
The development of a recommended longitudinal cognitive
assessment strategy consisted of several steps. First, a decision
was made to focus on quantitative measures that detect subtle
preclinical cognitive dysfunction. Second, it was decided to
expand criteria for test selection beyond outcomes that solely
depend on clinical diagnosis of neuropsychiatric disorders, as
this strategy could miss more subtle dysfunction in children at
critical ages and has little power to describe cognitive develop-
ment. Further, the list of critical domains and the stages of
development that should be evaluated required definition. Using
this framework, the list of tests and test batteries that evaluate
these domains was developed and the tests were then reviewed
according to a set of criteria.
Throughout this process, existing clinical and scientific
knowledge about child development was supplemented with
literature on developmental neurotoxicology, which describes
the relationships between exposure to common environmental
chemicals and their effects on brain function. Studies in this
field have taken advantage of the power of cognitive develop-
mental tests as measures of brain function and have thus
produced important information on domains of cognitive
function that are especially vulnerable to the subtle effects of
environmental influences, ages at which particular vulnerabil-
ities may appear in specific functional domains, effect sizes of
subtle deficits attributable to environmental influences and test
instruments that are especially useful to detect subtle cognitive
deficits in children.
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developed for test selection, a subset of tests was identified
and further explored for inclusion in a proposed assessment
battery. In addition, strategies for assessing children at
critical stages during development were considered. It should
be noted that the development of a battery to be used over
long periods of time relies on the state of the art in the field
at present. Therefore, one must anticipate that tests and test
strategies will be adjusted at intervals as long-term studies
progress.
Overview of tests and test batteries available
Many cognitive and neuropsychological tests have been
published that directly or indirectly assess the domains
described above. A compendium that was too extensive to
publish with this paper is available on the NICHD website
(http://www.nationalchildrensstudy.gov/research/reviewsreports/
Pages/Neuropsychological-Assessments-in-Children-from-a-
Longitudinal-Perspective-for-the-National-Children-s-Study.pdf).
It includes approximately 135 tests and scales that are listed
by domains of research interest and include applicable age
ranges. Included in that table are five of the most commonly
used batteries that have been recommended for evaluating
children and adults with suspected or known exposure to
chemical toxicants. The listings are not exhaustive but include
all tests considered for inclusion in the recommended battery.
Some other types of novel tasks and tests are mentioned in
this paper even though they do not exist as published
standardised tests.
Criteria used in test review
The tests listed in the compendium were reviewed by RFW and
a shorter list of tests was selected as candidate screening tasks.
Criteria for test selection are discussed below.
Place of test in child development literature
Tests were considered with regard to their place in the field of
developmental psychology. Tests that have been in widespread
use by clinicians and researchers were given preference. This
was done for several reasons. First, such tests are generally
feasible with regard to administration. Second, they are more
interpretable because they are associated with more published
information concerning the relationship of test outcomes to
particular types of developmental disorders (eg, attention,
learning disabilities, speech and language disorders, extremes
in IQ, motor deficits), neurological diseases (eg, epilepsy, brain
tumours, traumatic brain injury), neuropsychiatric disorders
(eg, autism, childhood depression, personality disorders, post-
traumatic stress disorder, anxiety), medications and medical
conditions (eg, genetic disorders affecting cognition, metabolic
disorders, respiratory diseases). Such information contributes to
the capacity of the tests to assist in screening (for triaging
children on to other evaluations) at the same time they serve as
outcome measures. In addition, structure-function relationships
have been described for many of the tests, relating impaired
performance on certain tests (or patterns of impaired and
retained performance on groups of tests) to particular structures
of the CNS. This knowledge is critical in that it may allow
investigators to form hypotheses concerning the structural or
functional elements of the CNS that may be affected by
exposures. These hypotheses can serve as the basis for further
investigations (eg, sophisticated neuroimaging).
Place of test in the neurotoxicant literature
If tests had proven sensitivity to low level and subtle effects of
chemical exposures, they were high on the candidate list for
exploring exposure-outcome relationships in a large epidemio-
logical screening study where toxicant exposure is being
measured. They also may have value in examining the subtle
effects of other types of exposure (eg, stress, violence,
medications, drugs, stimulus deprivation or overstimulation,
undernourishment/overnourishment/malnourishment). The
website cited above includes extensive tables that summarise
the developmental neurotoxicology literature that included
standardised test outcomes.
Construct validity
Priority was given to tests that have demonstrated ability to
assess specific domains. In addition, an attempt was made to
identify tests that could reliably assess a specific cognitive
process (or a set of processes) within a domain, and it was also
deemed necessary to balance the types of tests used within and
across domains at specific ages.
Demographics
Preference was given to tests for which the effects of age (in
months at the younger ages) and gender have been defined/
quantified. It was critical to include tests with a wide age range
since longitudinal studies may follow individuals from birth to
age 20. Effects of parental education and intelligence were also
considered, if available.
Culture/ethnicity/language
Available data on the relationships between culture and
language and test performance were also considered. Are there
ethnicity/cultural effects on test performance, and if so, what
are they? Are there special versions of the tests for children from
specific subcultures? How ‘‘culture-fair’’ is the test? Also
considered were effects of primary languages and multilingual-
ism on test performance, including availability of the tests in
languages other than English. Information was not available on
these variables for many of the tests, but tests with such
information received special consideration.
Psychometrics
Sensitivitytosubtleeffectsofexposuresrequiresteststhatpossess
certain psychometric characteristics. These include a sufficient
range of outcome scores and variance to reliably identify
exposure-outcome relationships. They must also be reliable
(especially with regard to test-retest reliability), that is, result in
similar scores in the same person when measured at repeated time
points with no change in exposure. It is also important that they
have demonstrated validity with regard to the construct they are
measuring as demonstrated by their relation to other known tests
(see above). Priority was also given to tests that are well
standardised. Availability of appropriate normative values for
test performance at different ages and for other variables was
considered to be important for certain purposes (eg,characterising
cohort performance relative to the US population). However, for
data analysis purposes, raw scores are usually the outcome of
choice in epidemiological studies.
Other factors
Other test characteristics that were considered important
include ease of administration, acceptability to children,
acceptability to parents, reasonable difficulty levels without
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the test to contribute to screening/triaging. Participant burden
is a major issue and even outstanding measures were discarded if
it they are too time-consuming to allow inclusion of other
required measures. Finally, it must be stated that RFW’s
experience using the tests in research and clinical settings
played a role in the test review. Batteries were limited in
administration time to 1–2.5 h, depending on age.
Battery design and testing strategy for prospective
developmental assessments
The literature on exposure-outcome relationships is incomplete
with regard to data on age at exposure and age at which
exposure effects can be detected. For example, the neurotox-
icology literature suggests that lead exposure in early childhood
is associated with IQ changes
5 and that prenatal methylmercury
exposure is associated with domain-specific neuropsychological
effects at the age of 7 years.
6 However, systematic studies across
ages of exposure, ages at which outcomes are measured and
specific toxicants do not yet exist. It is therefore difficult to
pinpoint critical ages at which specific types of neuropsycho-
logical outcomes should be measured.
Given the existing knowledge, it appears that the optimal
strategy is to acquire outcome data at as many ages as possible.
Because practice effects are large and can overwhelm subtle
exposure effects, it is not recommended that each child be tested
every year. A strategy that would allow the collection of data in
yearly age increments but prevent practice effects is to divide a
large cohort into groups of children. Testing each child every
4 years beginning at age 3–6 would result in neuropsychological
outcome data on a large group of children at each age. Before age
3, it is recommended that the four groups of children be tested
at 6 months, 1 year, 1.5 years or 2 years. This strategy is
outlined in table 1, which gives an age 6 domain 6 test
representation of a recommended battery. Each of the four
subgroups of children is designated by the letters A, B, C and D.
This strategy also allows repeat testing with certain key tasks at
widely divergent ages, facilitating longitudinal follow-up on
exposure-outcome relationships.
The testing strategy necessarily initiates testing of different
domains at different ages. For example, executive function
testing is not introduced until age 7. Testing of learning and
memory is limited before age 7. These recommendations reflect
the developmental curve of domain-specific skills as well as the
availability of tests appropriate for certain ages. These factors
are discussed in greater detail below.
The testing strategy allows for the introduction of different
tests that assess the specific domains at different ages. Using this
strategy, domain-specific findings observed on one test can be
evaluated somewhat later with a similar test from the same
domain, allowing a chance to evaluate convergent validity. It is
alsopossible toexaminemorethanonespecificaspectofcognitive
processingwithineachdomain.Indesigningthebattery,attempts
havebeenmadetoevaluateparallelaspectsofcognitiveprocessing
during each age range and within each domain.
Consideration was given to using the neuropsychological
outcome measures as ‘‘triggers’’ prompting complete diagnostic
evaluations in children who may have specific types of
developmental disorders. Thus, the recommended battery
incorporates the ages and criteria for using outcome measures
to triage children into screening for mental retardation,
disorders of attention and learning, motor coordination deficits,
autism and neurological disorders.
Finally, the views presented here are guided by personal
experience of RFW, which includes 30 years of work in research
and clinical settings assessing individuals across the lifespan.
This work has included prospective evaluation of children with
environmental exposures during infancy and early childhood,
cross-sectional research on environmental toxicant exposures in
childhood, occupational exposure studies with adults and the
long-term evaluation of neurodegenerative disorders in elderly
subjects. In all of this research, neuropsychological test
techniques have been applied as a method for uncovering the
underlying neuropathological mechanisms of action for cogni-
tive development. The battery described below is viewed as a
starting point in planning cognitive and neuropsychological
assessments of a large cohort at various ages.
RESULTS
Recommended neuropsychological outcome battery and
alternative tests
Table 1 summarises the recommended test battery to be
administered at each age level for each proposed domain. The
age ranges cover 2 years at the lowest level (with 6-month
intervalsfor testing until age 2) and 4 years afterthat untilage 19–
20 years (so that 25% of the cohort is tested at each age). A
suggested testing schedule in a large study could therefore contain
four groups: Group A: 25 000 children tested at ages 5, 3, 7, 11, 15
and 19 yearsof age ;Group B:25 000 children testedatages1,4, 8,
12, 16 and 19 years of age; Group C: 25 000 children tested at 1.5,
5, 9, 13, 17 and 20 years of age; Group D: 25 000 children tested at
2, 6, 10, 14, 18 and 20 years of age. It is noteworthy that this
approach can also be used with other testing strategies in mind.
For example, if all study population children were to be tested at
fixed ages, the set of tests recommended for each designated age
could be administered. The reader is also referred to the NICHD
website (http://www.nationalchildrensstudy.gov/research/analy-
tic_reports) which includes other details about the tests described
inthissection.Therationaleforchoosingthetestsforeachdomain
will be reviewed, along with a summary of the advantages and
disadvantages of each test for both recommended and alternative
tests. A brief section will follow describing special requirements of
test administration during each of the six proposed age ranges and
screening possibilities during some testing cycles.
Assessment domains by age omnibus intelligence (IQ) and
abilities measures
These measures assess potential exposure effects on omnibus
measures of general mental abilities at ages that have proved to
be critical in previous studies (0–2 and 3–6 years), ages at which
such measures are relatively stable and should reflect IQ across
childhood (7–10 years), and at an age when long-term effects on
IQ of earlier exposures can be evaluated (15–18 years).
For age 0.5–2 years, the Bayley Scales of Infant Development-
II
7 are recommended. Although other scales exist (eg, Fagan test,
Brazelton Scale), the Bayley Scale has the best standardisation
and has been used extensively in previous exposure-outcome
research. For example, it has been applied to assess the effects of
lead,
8–12 PCBs,
13–15 methylmercury
16–18 and dichlorodiphenyldi-
chloroethylene.
19 20 Although the Bayley Scale is a fairly blunt
instrument that may not pick up subtle deficits associated with
exposures and the items are rather diverse (ie, they do not easily
lend themselves to domain-specific analysis), it is the best
option available. It is recommended that this test be given to the
cohort subgroups at one time point each (6 months, 1 year,
1.5 years or 2 years).
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Age at testing Battery length (min)
Group(s) to be
tested Tests
6 months 20 A Screening domain: Bayley-II
1 year 20 B Screening domain: Bayley-II
1.5 years 30 C Screening domain: Bayley-II
2 years 30 D Screening domain: Bayley-II
3 years 60 A IQ domain: WPPSI-III (block design, matrix reasoning, vocabulary subtests)
Attention domain: Conners Rating Scale-R
Language domain: EVT (naming subtest); PPVT-III
Visuospatial domain: Beery Visual-Motor Integration Test-5
Motor domain: Revised Purdue Pegboard
Novel/pilot tests (group C)
4 years 75 B IQ domain: WPPSI-III (block design, matrix reasoning, vocabulary subtests)
Attention domain: Conners Rating Scale-R; Conners CPT-II
Language domain: EVT (naming subtest); PPVT-III
Visuospatial domain: Beery Visual-Motor Integration Test-5
Learning and memory domain: Coding recall (Wechsler test)
Motor domain: Revised Purdue Pegboard; Coding subtest (Wechsler test)
Novel/pilot tests (group D)
5 years 95 C IQ domain: WPPSI-III (block design, matrix reasoning, vocabulary subtests)
Attention domain: Conners Rating Scale-R; Conners CPT-II
Language domain: EVT (naming subtest); PPVT-III
Visuospatial domain: Beery Visual-Motor Integration Test-5
Learning and memory domain: CVLT-Children’s edition; WRAML-2 (stories subtest)
Coding recall (Wechsler test)
Motor domain: Revised Purdue Pegboard; Coding subtest (Wechsler test)
Novel/pilot tests (group A)
6 years 95 D IQ domain: WPPSI-III (block design, matrix reasoning, vocabulary subtests)
Attention domain: Conners Rating Scale-R; Conners CPT-II
Language domain: BNT; PPVT-III
Visuospatial domain: Beery Visual-Motor Integration Test-5
Learning and memory domain: CVLT-Children’s edition; WRAML-2 (stories subtest); Coding
recall (Wechsler test)
Motor domain: Revised Purdue Pegboard; Coding subtest (Wechsler test)
Novel/pilot tests (group B)
7 years
8 years
9 years
10 years
145
145
150
150
A
B
C
D
IQ domain: WASI (block design, matrix reasoning, vocabulary, similarities subtests)
Academics: Wide Range Achievement Test 3 (spelling, arithmetic, reading subtests)
Attention domain: Conners Rating Scale-R; Conners CPT-II; Digit Span Forwards (Wechsler
test)
Executive function domain: WCST
Language domain: BNT; PPVT-III
Visuospatial domain: Bender Gestalt-II
Learning and memory domain: Bender Gestalt-II (recall condition); CVLT-Children’s edition;
WRAML-2 (stories subtest)* stimuli changes at age 9; Coding recall (Wechsler test)
Motor domain: Grooved Pegboard; Finger Tapping Test; Coding subtest (Wechsler test)
Novel/pilot tests (7 years group C; 8 years group D; 9 years group A; 10 years group B)
11 years
12 years
13 years
115
115
115
A
B
C
Attention domain: Conners’ CPT-II ; Digit Span Forwards (Wechsler test)
Executive function domain: Digits Backwards (Wechsler test); TMT
Language domain: EVT; CELF-4 (sentence structure subtest)
Visuospatial domain: HVOT; ROCF; Berry Visual Motor Integration Test-5
Learning and memory domain: ROCF (recall condition); WRAML-2 (stories and verbal
learning subtests); Coding recall (Wechsler test)
Motor domain: Grooved Pegboard; Finger Tapping Test; Coding subtest (Wechsler test)
Novel/pilot tests (11 years group C; 12 years group D; 13 years group A
Continued
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Preschool and Primary Scale of Intelligence (WPPSI-III)
21
(Block Designs, Matrix Reasoning and Vocabulary) is
recommended. The WPPSI-III was chosen over other possi-
bilities for several reasons. The Wechsler scales have been the
most extensively applied to IQ research on this age range in
the past and they dovetail nicely with Wechsler subtests
available at later ages. The subtests chosen will produce an
IQ score, have parallel versions available at later ages and can
contribute some information to domain-specific function
(although they are far from pure measures of specific
domains). The major disadvantage of the Wechsler Scales is
that they have somewhat abbreviated ranges, meaning that
at the lowest and highest age ranges the tests can be too
difficult or too simple and that persons with low IQs or
those who are gifted may be ‘‘out of range’’ (ie, unable to
meaningfully complete subtests or able to correctly complete
all or virtually all items).
Other tests that were considered for this age span include the
McCarthy,
22 which has also been used extensively in develop-
mental research. The major disadvantage of this test is the
limited number and heterogeneity of items in specific subscale
areas. The Stanford Binet Intelligence Scale-V
23 was also
considered. The major advantage of this test is that it can be
given across the lifespan, frequently using the same subtests. It
is also excellent for measuring the higher and lower ends of
intelligence. Disadvantages include limited use in developmental
research, less information on relationships between subtest
performance and developmental outcomes, and the fact that
there is limited experience with the most recent edition of the
scale. The publishers have significantly altered the test; an
important omission from the new version appears to be the
copying test, which proved to be very sensitive in several
cultures at several ages to the effects of prenatal and childhood
exposure to methylmercury. Finally, the Kaufman scales
(KABC-2, KBIT-2)
24 25 were considered. These scales have also
Table 1 Continued
Age at testing Battery length (min)
Group(s) to be
tested Tests
14 years 120 D Attention domain: Conners Rating Scale-R; Conners CPT-II; Digit Span Forwards (Wechsler
test)
Executive function domain: Digits Backwards (Wechsler test); TMT
Language domain: EVT; CELF-3 (sentence structure subtest)
Visuospatial domain: HVOT; RCOF; Berry Visual-Motor Integration Test-5
Learning and memory domain: ROCF (recall condition); WRAML-2 (stories and verbal
learning subtests); Coding recall (Wechsler test)
Motor domain: Grooved Pegboard; Finger Tapping Test; Coding subtest (Wechsler test)
Novel/pilot tests (group B)
15 years
16 years
160
160
A
B
IQ domain: WASI (block design, matrix reasoning, vocabulary, similarities subtests)
Academics: Wide Range Achievement Test 4 (spelling, arithmetic, reading subtests)
Attention domain: Conners Rating Scale-R; Conners CPT-II; Digit Span Forwards (Wechsler)
Executive function domain: Digits Backwards (Wechsler); WCST
Language domain: BNT; PPVT-III
Visuospatial domain: Bender Gestalt-II
Learning and memory domain: Bender Gestalt-II (recall condition); CVLT-II; WRAML-2
(stories subtest); Coding recall (Wechsler)
Motor domain: Grooved Pegboard; Finger Tapping Test; Coding subtest (Wechsler)
Novel/pilot tests (15 years group C; 16 years group D)
17 years
18 years
155
150
C
D
IQ domain: WASI (block design, matrix reasoning, vocabulary, similarities subtests)
Academics: Wide Range Achievement Test 4 (spelling, arithmetic, reading subtests)
Attention domain: Conners Rating Scale-R (not at age 18); Conners CPT-II; Digit Span
Forwards (Wechsler test)
Executive function domain: Digits Backwards (Wechsler test); WCST
Language domain: BNT, PPVT-III
Visuospatial domain: Bender Gestalt-II
Learning and memory domain: Bender Gestalt-II (recall condition); CVLT-II; Wechsler
Memory Scale-III (logical memory subtest); Coding recall (Wechsler test)
Motor domain: Grooved Pegboard; Finger Tapping Test; Coding subtest (Wechsler test)
Novel/pilot tests (17 years group A; 18 years group B)
19 years
20 years
85
85
A and B
C and D
Attention domain: Conners CPT-II
Executive function domain: TMT
Language domain: EVT; CELF-4 (sentence structure subtest)
Visuospatial domain: HVOT; ROCF
Learning and memory domain: ROCF (recall condition); CVLT-II; Wechsler Memory Scale-III
(logical memory subtest)
Motor domain: Grooved Pegboard; Finger Tapping Test
Novel/pilot tests (19 years group A and B; 20 years group C and D)
BNT, Boston Naming Test; CELF, Clinical Evaluation of Language Fundamentals; CVLT, California Verbal Learning Test; CPT, Conners Continuous Performance Test; EVT, Expressive
Vocabulary Test; HVOT, Hooper Visual Organization Test; PPVT, Peabody Picture Vocabulary Test; ROCF, Rey Osterrieth Complex Figure; TMT, Trail Making Test; WASI, Wechsler
Abbreviated Scale of Intelligence; WCST, Wisconsin Card Sorting Test; WPPSI-III, Wechsler Preschool and Primary Scale of Intelligence; WRAML, Wide Range Assessment of
Memory and Learning.
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recently undergone significant revision, raising questions about
their comparability to previous versions of the tests. The Raven
Progressive Matrices Test
26 has been used in the past in toxicant
exposure studies. This test has been successfully applied in
many cultures and appears to possess inherently less cultural
and linguistic bias than other intelligence tests. However, the
Raven test assesses intelligence in a one-dimensional fashion (a
type of non-verbal executive function) and supportive psycho-
metric data for the test are limited with regard to norms,
validity and reliability.
At ages 7–10 and 15–18 years the Wechsler Abbreviated Scale
of Intelligence (WASI)
27 is recommended to assess the general
abilities domain. This test has four subtests (Block Designs,
Matrix Reasoning, Similarities and Vocabulary) that provide
continuity with the WPPSI-III subtests recommended for
children aged 3–6 years. In addition, the WASI can be used
across the lifespan after age 6 using the same subtests. Another
possibility for children aged 7–10 years is the Wechsler
Intelligence Scale for Children (WISC)-IV,
28 a revised version
of the earlier WISC scales (WISC, WISC-R, WISC-III) which
have been used extensively in developmental research. The
WASI was recommended over the WISC-IV owing to its greater
brevity and its continuity across the developmental span.
For the 15–18 age range, inclusion of a full Wechsler
assessment would require use of both the WISC-IV and the
WAIS-III, switching tests at age 16 or 17 years. This would
produce less continuity in the age range testing, and both scales
can be problematic for 16-year-old subjects (too easy or too
hard).
The NEPSY
29 was considered as an alternative test for both
omnibus scores and domain-specific assessment and is seen as
an alternative instrument. The test seems to have a rather low
ceiling and subtest length is somewhat limited, restricting the
utility of outcome data.
When discussing the neuropsychological domains below,
subtests from the IQ tests and the NEPSY can always be
considered to be possible alternative tasks. The pros and cons of
these tests have been described above and will not be repeated.
Academic screening
A domain for brief academic testing was included as an assist to
screening for learning disorders. This domain was not designed
to serve as a full assessment of academic abilities as outcome
measures, although the results can be used as a cursory
evaluation of these outcomes at the age ranges in which they
are included. In children aged 7–10 years, brief testing of basic
academic skills can be combined with results of IQ and domain-
specific testing in order to identify those who may have
disorders of learning. The test recommended for this domain is
the Wide Range Achievement Test-4 (WRAT-4),
30 which
assesses single-word reading, single-word spelling and arith-
metic. This test was selected for ease of administration, time
efficiency and its acceptance in the field. It has seen limited use
in exposure studies. Alternative tests include the Woodcock-
Johnson
31 which was used in a study of methylmercury, the
Kaufman Test of Individual Achievement-2 and the Wechsler
Individual Achievement Test.
32 These tests are more complex
than the WRAT-4 and less suited to screening. It is recom-
mended that the WRAT-4 be repeated during the 15–18 age
testing in order to assess stability of any exposure-related
changes in basic academic skills over time.
Attention/concentration
The cognitive processes subsumed under this domain have been
widely described and evaluated in the cognitive psychology
literature. Since it is not possible to assess all aspects of the
domain, this assessment strategy focuses on behaviour, sus-
tained attention/reaction time and spans of apprehension.
Tests recommended for this domain among 3–6-year-old
children include the Conners Rating Scale-Revised
33 and the
Conners Continuous Performance Test (CPT)-II.
34 The Conners
Rating Scale is used to assess behavioural characteristics that are
associated with attention deficit hyperactivity disorder (ADHD)
as defined by the Diagnostic and Statistical Manual-IV (DSM-
IV). Outcomes include both a score that can be used as a
quantitative outcome measure and assignment of a provisional
diagnosis of ADHD based on cut-off criteria. Thus, the test can
contribute to screening for ADHD in this age range. Testing
with the Conners CPT-II begins at age 6, and the test allows
evaluation of lapses in attention (omission errors), over-
responding (false positives) and reaction time. Reaction times
have proved to be sensitive indicators of exposures to toxicants
and medications. The Conners CPT-II was recommended
because of its widespread use in child clinical neuropsychology.
Span of apprehension testing (Wechsler Digit Span Forward) is
not recommended for this age group owing to limited
applicability at the age of 3–5 years.
For children aged 7–10 years, it is recommended that the
Conners Rating Scale-Revised be repeated in order to acquire a
second set of outcome scores on attentional behaviours and to
allow a second chance to pick up possible cases of ADHD that
were missed at previous testing. The Conners CPT-II is also
recommended at all ages due to the sensitivity of reaction time
data to many types of exposures/insults/disorders. Finally, the
Wechsler (WISC-IV) Digit Span Forward test is recommended
as a span of apprehension task. This task provides data on the
number of bits of information that the child can automatically
register and repeat back. Such data are important as outcome
measures (and have been related to specific types of exposures
during development). They can also be used to estimate
appropriate expectations for performance on learning tests.
Other possibilities include the Neurobehavioral Evaluation
System (NES) letter or animal CPT,
35 which has also been used
extensively and effectively in detecting subtle toxicant effects in
children and adults. The NES is less widely available and more
difficult to adapt to different testing situations than the
Conners test. Normative and psychometric data are also less
extensive for it. A visual pointing span test is another
alternative.
For children aged 11–14 years, it is recommended that the
Conners CPT-II and the WISC-IV Digit Span Forward be
repeated. At age 14 the Conners Rating Scale-R can be repeated
to assess stability of scores and cut-offs for ADHD diagnosis
criteria.
At ages 15–18, it is recommended that the Conners CPT-II
and Wechsler Digit Span Forward assessment be repeated
(WISC-IV for ages 15–16; WAIS-III for ages 17–18). The
Conners Rating Scale-R can be repeated at ages 15, 16 and
17 years.
At ages 19–20 the recommended attention test for the brief
battery is the Conners CPT-II.
Executive function/working memory
This domain is a complex one and related skills tend to develop
somewhat later than those subsumed under other domains.
Since it would be impossible to evaluate all aspects of this
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few skills at each age level. The tests chosen for the age ranges
between 3 and 18 years were selected to include both visually
and verbally mediated tasks.
Proposed testing begins in the 7–10 year age range. The
Wisconsin Card Sorting Test (WCST)
36 is a widely used task
assessing this domain. It taps inferential reasoning, working
memory, capacity to attain and switch sets flexibly, and ability
to inhibit distractions and perseverative tendencies.
Performance on this test has been related to a wide variety of
neurological and developmental disorders, neuropsychiatric
syndromes and exposures to chemical toxicants. A second test,
the WASI Similarities test, is administered as part of the general
intelligence testing and also taps aspects of executive function.
This task assesses abstract reasoning and its performance scores
have been related to aspects of normal and abnormal child
development. The Children’s Categories Test
37 is an alternative
test for the same domain. It has two levels (for ages 5–8 and 9–
13 years), so the test stimuli are different for children tested at
ages 7 and 8 years than for those tested at 9 and 10 years. A few
of the items are slightly problematic. Other tests that assess this
domain that can be considered as alternatives for use in the 7–
10 year range include the Children’s Color Trails Test
38 (age 8–
10 years) and the Stroop Color Word Test.
39 The Color Trails
Test appears to be relatively culture fair but has (in RFW’s
experience) been difficult to administer (many children do not
understand it initially). There is also much less information
about how performance on this test relates to other aspects of
childhood cognitive development than is available for other
tests of executive function. The Stroop Test is commonly used
as an executive test and much more is known about its
relationship to other variables. However, performance on the
test varies widely, affecting reliability and psychometrics of the
test for data analysis purposes.
The executive domain tests recommended in table 1 for the
11–14 age group are Wechsler (WISC-IV) Digit Span Backward,
a working memory task requiring the registration and manip-
ulation of verbal information, and the Trail Making Test
(TMT)
40 which requires the examinee to track and connect
visual information (A condition) and to alternate sets while
tracking and connecting visual stimuli (B condition). Both tests
have rich sources of scientific and clinical data to support their
use and interpretation in a study such as this. Drawbacks to the
Digit Span Backward include resistance to the task by
examinees who feel they cannot manipulate numbers as well
as the need for considerable examinee cooperation in completing
it. The TMT is a timed task and optimal performance is only
elicited when the examinee is willing to work as quickly and
accurately as possible. It also requires automatic knowledge of
the alphabet sequence and numbers. Alternative tests include
the tests described above for examining this domain in children
aged 7–10 years.
For testing in the 15–18-year age group, it is recommended
that Wechsler Digit Span Backward (WISC-IV for age 15–
16 years, WAIS-III for age 17–18 years), the WCST and WASI
Similarities be repeated. Other possibilities include the
Children’s Categories Test (Level 2),
37 Children’s Color Trails
38
(1–17) and Color Trails
41 (age 18 years). Pros and cons of these
tests have been noted above. Another alternative is the Paced
Auditory Serial Addition Test (PASAT),
42 a rather difficult task
that was developed to demonstrate subtle brain damage
associated with head injuries. A strength of this test is its
sensitivity to subtle processing deficits. However, because it
requires considerable examinee cooperation, performances tend
to be rather variable. It is not as well represented in the general
developmental cognitive literature as some of the other tests
mentioned.
The recommended executive domain task for the brief testing
of subjects aged 19–20 years is the TMT, repeated 7–8 years
after initial presentation to the cohort. This is a highly sensitive
and efficient test that is also well investigated and appropriate
for young adults.
Language/verbal skills
Goals for assessment of this domain include examination of
lexical knowledge, simple verbal comprehension and ability to
define vocabulary words while allowing preliminary screening
for speech disorders and verbally-based learning disabilities at
the younger ages. The group of tests recommended for each age
range includes tasks assessing both expressive and receptive
aspects of language skills.
During the assessment of children aged 3–6 years it is
recommended that simple naming of objects be evaluated.
Both tests recommended for the assessment of naming require
the child to name objects presented in drawings or pictures. The
naming portion of the Expressive Vocabulary Test (EVT)
43 is
recommended for children aged 3–5 years. The EVT was chosen
because of its applicability for expressive language during
childhood and the particular balance of naming/synonyms in
assessment of language function over development. At 6 years
of age a different naming test must be applied. The Boston
Naming Test (BNT)
44 is recommended owing to its feasibility
from the age of 6 years through adulthood and its known
effectiveness in detecting subtle effects of prenatal exposure to
toxicants such as methylmercury. It has been applied in widely
diverse cultures and subcultures and translated into many
languages. Another possible test that could be used to evaluate
naming in this age range is the WPPSI-III Naming Test which
can be administered at all four ages (3–6 years), although it does
not have a parallel version for use at later ages.
The Peabody Picture Vocabulary Test-III (PPVT-III)
45 is
recommended as a test of receptive language or language
comprehension for this age range. It has a number of
advantages, including ease of administration, well-documented
reliability and validity, extensive norms, well-defined psycho-
metrics and widespread use in the field. Similarly, the Token
Test for Children
46 has normalised scores for ages 3–12 (in 6-
month increments). It was developed as a rapid screening
measure of language competence, particularly for children with
receptive language dysfunction that depresses language scores.
Both tests are appropriate but the Token Test was selected as an
alternative to the preferred PPVT because it is less process-
specific in its task demands.
It is recommended that assessment of ability to provide
definitions of words be carried out with the WPPSI-III
Vocabulary Test, a test with the same advantages as PPVT-
III. Another assessment, the Clinical Evaluation of Language
Fundamentals-IV (CELF-4)
47 includes both expressive and
receptive subtests, one of which is also recommended for use
at a later age level. However, most of the CELF-4 subtests
appear to be less appropriate for screening in the 3–6-year age
group than those included in the recommended list.
At ages 7–10 years the BNT is recommended as an assessment
tool for expression/naming, the PPVT-III for comprehension/
receptive speech and the WASI Vocabulary subtest for produc-
tion of word definitions. Pros and cons of these tests and
alternative tasks are noted above.
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year age group include two new tasks that allow examination of
a slightly different aspect of expressive and receptive processing
and thus reduce practice effects across the age ranges. The EVT
Synonyms task (requiring the examinee to produce words with
the same meaning as those given orally by the examiner for a
stimulus picture) and the CELF-4 Sentence Structure subtest (a
receptive task requiring recognition of words appropriate to
sentences) are recommended for this age range. These tasks are
less well known than the language tests recommended for
earlier age ranges but have been well standardised and normed
and will provide information on more complex aspects of
expressive and receptive language at this age level.
For the language/verbal assessment at ages 15–18 years, it is
recommended that the BNT, PPVT-III and WASI Vocabulary
subtest be repeated.
The recommended brief language domain assessment at ages
19–20 years includes repetition of the EVT (Synonyms) and
CELF-4 Sentence Structure subtest. It is also possible to repeat
the BNT or PPVT-III or to apply other language tasks.
Visuospatial abilities
The critical processes that must be evaluated in the assessment
of visuospatial abilities have been less well defined than those of
other domains, and there has been considerable overlap in the
stimuli used across visuospatial tasks designed for children. To
accommodate potential individual differences, it was deemed
important to include both traditional constructional tasks (with
a motor component such as drawing or putting blocks or puzzle
pieces together) and motor-free tasks that involve visuospatial
processing and integration at a cognitive level only.
The visuospatial tasks recommended for use at ages 3–6 years
include the Visual Motor Integration Test (VMI-5).
48 This task
is well embedded in the developmental literature and has
recently been revised and renormed. It has been used in previous
work involving environmental toxicant exposure and was
chosen partially for its similarity to the Copying Test of the
Stanford Binet-IV.
23 The latter task was highly feasible in several
cultures and able to detect subtle effects of early exposures to
methylmercury. The Copying Test was also valuable because it
could be administered across the lifespan, a property not
associated with the VMI-5. However, the two tests have
overlapping stimuli and test requirements. An alternative
constructional test is the Bender Gestalt-II.
49 The original
version of this test has been used extensively in both clinical
and research situations and has detected effects of toxicant
exposures. However, for this age range the test could only be
administered at ages 5 and 6 years. The WPPSI-III
21 Block
Designs and Matrix Reasoning subtests are recommended for
the 3–6-year age range. They provide a measure of visuospatial
skills with a motor component (Block Designs) and a test
without motor requirements (Matrix Reasoning). Both have a
strong executive component (as do many visuospatial tests).
They also contribute to the IQ score recommended for this age
group.
The Block Designs and Matrix Reasoning subtests of the
WASI are recommended for the 7–10-year age range.
Advantages and drawbacks are similar to those described for
the subtests at ages 3–6 years, though the WASI subtests can be
given across the lifespan after age 6. A second recommended
visuospatial task for children aged 7–10 years is the Bender
Gestalt-II, a visual constructional task similar to the initial
version used in prior research but with additional designs added
for a better range of scores and difficulty level. Experience with
the revised version is still somewhat limited. It has a recall
condition, an advantage that contributes to the test’s efficiency
in a battery such as that to be used for the National Children’s
Study.
For children aged 11–14 years, three tests are recommended.
Repetition of the VMI-5 is suggested as a measure of visual
constructions. The Hooper Visual Organization Test (HVOT)
50
is recommended as a motor-free task assessing visual integra-
tion. The test has a somewhat low ceiling in adults, but is one of
the few tests available that allows examination of visual
organisation without drawing or assembling concrete objects.
Finally, the Rey-Osterreith Complex Figure (ROCF) test
51 is
recommended for use in this age range. The ROCF is a relatively
difficult construction that increases the range of assessment of
the visuospatial domain, can be given quickly, is well known to
clinicians and researchers in child development and includes
memory conditions. Scoring of the ROCF can be done simply,
although complex scoring systems have been developed for it.
This task also produces a wealth of qualitative information that
may be useful for certain kinds of data analysis.
The visuospatial tasks recommended for the 15–18-year age
group assessments include the Bender Gestalt-II and two WASI
subtests (Block Designs and Matrix Reasoning).
For the 19–20-year age group the brief visuospatial battery
recommended includes the motor-free HVOT and the ROCF to
assess constructional ability.
Learning and memory
As noted in the definitions above, learning and memory
function involve several key cognitive processes. Luckily, several
tests of learning and memory have been developed that address
all or most of these functional processes. For the recommended
battery, this domain is focused on anterograde memory rather
than retrograde memory or procedural learning. Because
children differ in their verbal and visuospatial abilities and
because the cerebral structures subserving the processing of
verbal and visual information are different, visual and verbal
memory tests are included at each age level. Similarly, within
the verbal modality, learning lists of words or word-pairs can be
differentiated on a neural system or neurofunctional basis from
learning discourse or paragraph material. For this reason, both
word list and discourse tasks were included as much as possible
at each age level.
The battery for this domain is relatively limited in the 3–6-
year age range. Few tests are available and administration of
these kinds of tests is difficult for very young children. The
recommended test battery takes advantage of the use of the
WPPSI-III Coding Test at ages 4–6 years (see Motor domain
below) to carry out incidental learning of the symbol-symbol
pairs (visual memory task). At 5–6 years of age, administration
of the California Verbal Learning Test (Children’s version)
(CVLT-C)
52 is recommended. This is a list-learning test devised
to comprehensively assess learning and memory at several
levels, with learning, immediate and delayed recall conditions as
well as spontaneous and recognition test paradigms. It is thus a
rich test that provides considerable information. It is somewhat
time-consuming and some individuals resist list-learning tests,
but its advantages were judged to outweigh disadvantages. The
Wide Range Assessment of Memory and Learning-2 (WRAML-
2)
53 Stories subtest is also recommended for children aged 5–
6 years. The previous version of the WRAML has been used in
research of this type and appears to be solid with regard to
psychometrics and standardisation. It was recently revised, but
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have not significantly changed.
At 7–10 years of age the breadth of testing in this domain
widens considerably. Recommended tests for the assessment of
visual learning and memory include the recall condition of the
Bender Gestalt-II and incidental learning of the visual pairs from
the Wechsler-IV Coding subtest. For verbal learning the CVLT-
C list-learning test and WRAML-2 Stories test are again
recommended (stimuli for the WRAML-2 Stories test change
at age 9 years).
Recommended visual memory tasks at 11–14 years of age
include the recall condition of the ROCF and incidental recall of
the pairs from the WISC-IV coding tests. Verbal memory tests
included at this age range in the recommended battery include
the WRAML-2 Stories subtest and the WRAML-2 Verbal
Learning subtest (a list-learning task).
It is recommended that visual memory for 15–18-year-olds be
assessed using the immediate and delayed recall conditions of
the Bender Gestalt-II and incidental recall from the Wechsler
Coding subtest (WISC-IV at age 15–16 years, WAIS-III at age
17–18 years). Assessment of verbal list learning using the adult
version of the California Verbal Learning Test II (CVLT-II) is
recommended. For narrative or discourse learning, repetition of
the WRAML-2 Stories subtest is suggested for children aged 15–
16 years and the Logical Memory subtest of the Wechsler
Memory Scale-III (WMS-III) for those aged 16–17 years.
The recommended brief battery for assessment of learning
and memory at ages 19–20 includes the ROCF immediate and
delayed recall, CVLT-II and WMS-III Logical Memory.
54
Motor skills
There are few quantified fine motor tests for children or adults.
In designing the batteries to assess motor function, the decision
was made to recommend a simple test of motor speed, a more
complex test that invokes both speed and dexterity and an
integrative task. All recommended tests evaluate manual motor
speed with the hands, with at least one test at each age level
allowing comparison of the right and left hands.
The recommended assessment of motor function at ages 3–
6 years includes the Revised Purdue Pegboard.
55 This test is a
local adaptation and test instruments may have to be
constructed for assessing this domain in small children. At age
4, administration of the Wechsler Coding subtest begins (using
the WPPSI-III subtest). This task is highly sensitive to many
brain insults and developmental conditions but is not specific
with regard to localisation or diagnosis. The test itself is
completed manually and timed, but performance improves if
the child uses an effective strategy, has strong visual orientation
and/or visual scanning skills and can remember the stimuli.
Thus, the task requires integration of many abilities. However,
its inclusion is recommended based on its sensitivity. An
incidental memory condition can be used to enhance the
assessment of the memory domain as well (see above).
The recommended group of tests for evaluating this domain is
the same from ages 11 to 20 years. It includes the Fingertapping
Test
56 for a simple assessment of manual motor speed with each
hand. Computerised versions provide especially precise data on
Fingertapping and a system such as the Neurobehavioral
Evaluation System (NES) might be used, but it is important
that the testing be the same at all test sites. The mechanical and
automated tappers are standard, but sometimes malfunction
and may produce different data at different sites. Alternatives
include the NEPSY Fingertapping Task (done with the
examinee’s fingers), but this test is much less precise. The
Grooved Pegboard
57 is recommended to assess motor speed
involving dexterity/coordination with each hand. A standard
form board can be purchased. This test is widely used. It is
recommended over the Purdue Pegboard because it picks up
more subtle brain damage. The Santa Ana Formboard
58 has a
special place in the neurotoxicology literature and, like the
Grooved Pegboard, is more challenging than the Purdue.
Standard versions of it are not available, although they could
be constructed.
Other categories
Novel tests
This category was included in the matrix in order to indicate
propitious times at which study participants could undergo
other kinds of tests when they had not been tested for a while.
Thus, children from Group A who are tested at age 3 and not
scheduled for standard evaluation again until age 7 might
undergo another test battery at age 5. Applicable scenarios are
described below.
Pilot testing
Tasks to be introduced later or tests that are revised could be
piloted at these time intervals.
Evaluation of domains not included in the standard battery
Test batteries to assess domains such as prosody (expression,
comprehension), tactile and kinesthetic functions, retrograde
memory and procedural learning might be applied as deemed
appropriate or useful. In addition, a test of purposeful test
failure was not included since there does not seem to be
motivation for cohort members to fail tasks. However, under
certain circumstances, the introduction of such a test might be
warranted.
Animal test techniques
Tests adapted from animal studies could also be applied and
piloted. These might include existing operant tasks and tests
such as the Delayed Recognition Span Test
59 (a learning task
based on delayed non-matching to sample methodology).
Special studies
Substudies assessing special abilities or tasks exploring the
cognitive processes thought to subserve domains might be
applied at these times.
Age ranges
As noted in table 1, the six age ranges were selected to allow
testing of each child every 4 years from age 3–6 to 15–18 years,
with additional testing at age 0.5–2.0 and 19–20 years. It is
recommended that the age band before and after the target
age be restricted as follows: ¡1 month at age 0.5–2.0 years and
+0–3 months at ages 3–20 years.
Screening considerations
Test performance, especially at earlier ages, can be used as a
signal that further evaluation is necessary for possible disorders
or illnesses. At age 0.5–2.0 years, Bayley-II results could be used
to tag children for evaluation of mental retardation (.2
standard deviations below average on the Mental
Development Index), cerebral palsy or motor disorders (.2
standard deviations below average on the Psychomotor
Development Index) or autism (,10 percentile on the behaviour
rating scale).
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below the cut-off point can tag children for evaluation of
ADHD. Children scoring .2 standard deviations below average
on the Conners CPT-II or making large numbers of errors can be
considered for evaluation of other types of disorders (eg, autism,
neurological conditions such as epilepsy). Individuals with IQs
below 70 on the WPPSI-III can be tagged for possible evaluation
of mental retardation. Large discrepancies between verbal and
visuospatial skills on the WPSSI-III subtests accompanied by
similar discrepancies on the domain-specific tests could be used
to identify children at risk for speech disorders, learning
disabilities, neurological disorders or autism.
In children aged 7–10 years, those with borderline intelligence
or those who are gifted can be identified using WASI data.
Children with large discrepancies between verbal and perfor-
mance measures on the WASI who also show large discrepancies
between reading and arithmetic on the WRAT-3 can be
considered for evaluation of possible learning disorders.
Other considerations for test implementation and review
The following suggestions apply to implementation and data
collection of the neuropsychological data in future studies.
Pilot work
All tests should be piloted on a representative sample of children
before they are given to each group in order to confirm that time
allotted for the battery is accurate in the population being
assessed, to determine the best order of tests administered and
to identify feasibility issues such as acceptability to examinees,
variability in test administration among examiners and
cultural/language aspects of the tests that may not have been
anticipated.
Revised versions of tests
Virtually all of the tests included in a planned battery will be
revised over time, sometimes changing the task demands and
stimuli quite significantly. If this is done without the necessary
psychometric work, piloting of new tests will be required to
evaluate their comparability to the task already in use. It may be
necessary to decide whether to continue to use an ‘‘old’’ version
of a test or to implement the revised version. Obviously,
continued use of the older version will enhance comparability of
raw test scores across development. However, revised versions
of tests may be more useful for reporting or may better fit new
theories or knowledge about brain-behaviour relationships.
Adapting tests
Tests and test scoring rules may not apply to specific cultural or
linguistic groups. Care will be needed to address these issues
within the cohort, again with pilot testing, review of protocols
with regard to scoring and translation or development of
language- or culture-appropriate tests for certain groups of
children.
This document has noted that some children will have special
kinds of cognitive disorders that affect their performance. There
will be some children who cannot complete even the lowest
levels of the tasks recommended in the present battery. For
children who are identified with extremes in IQ (especially
children with borderline IQ or mental retardation but possibly
also children with very superior intelligence), it may be
necessary to develop specialised batteries for assessing domain-
specific functions. Children with learning disabilities or ADHD
but normal intelligence can be presented with the battery tasks,
although of course their disabilities will affect performance
levels and types of errors.
Sensory deficits may also present difficulties. Tasks can be
adjusted for children who cannot see or hear or who have motor
deficits. These adjustments should be standardised for the
cohort of children and noted in data summaries.
Data collection
Verbatim recording of examinee responses and the use of
answer sheets that allow the examiner to record approaches to
tasks and other aspects of performance will enhance the data
set. Generally, raw scores are most useful in studies of these
kinds for data analysis, although conversion to normative scores
may be useful for some purposes. It is generally impossible to
record all qualitative data in databases, although the most
relevant should be determined and included (eg, number of
phonemic errors on a naming test). When raw data are carefully
collected, qualitative findings can be reviewed and summarised
later if specific questions arise.
Examiners
Educational requirements for examiners should be carefully
considered. Licensed doctoral level psychologists with training
in assessment might be preferred since they are more likely to
respect standardisation rules or note possible disorders in
children as they are testing them. However, supervised master’s
What is already known on this subject
c Over the past 25 years, several neuropsychological test
batteries have been proposed for the assessment of central
nervous system (CNS) effects of environmental exposures on
CNS function in children.
c These have largely employed traditional tests of intelligence
quotient (IQ) or academic skills, although a few have taken a
broader approach including domain-specific tests of cognitive,
motor and affective function.
What this study adds
c A test battery aimed at assessing the effects of environmental
insults on CNS function that is longitudinal and cohort-focused.
c A wide-ranging test battery, including tests of IQ as well as
tasks that assess specific cognitive, affective and motor
domains.
c A test battery that employs a strategy of dividing a cohort into
groups so that, over time, all domains are tested in all age
groups from age 0.5–20 years.
c A test battery that uses a rationale for the tests chosen that
includes developmental appropriateness of domains assessed
and specific tests in each age range, including tasks that can
be repeated across time to determine changes in actual raw
scores on tests as children develop while at the same time
introducing new tests when necessary.
c A test battery that includes tests that have detected effects of
exposures to neurotoxic chemicals in past research, while at
the same time allowing for hypothesis-driven research that
explores the structural and functional underpinnings of these
effects.
Supplement
J Epidemiol Community Health 2009;63(Suppl I):i15–i26. doi:10.1136/jech.2007.071530 i25level licensed psychometrists are an option as are highly trained
bachelor’s level research assistants. Extensive training and
monitoring of examiners will be necessary, together with
evaluation of intra- and inter-examiner reliability of examiners.
Videotaping of testing is recommended.
Examinee effort
Effort on the part of the examinee will affect scores. It may be
useful to employ brief rating scales for indications of effort to be
filled out by both the examiner and the examinee.
Competing interests: None.
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